Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Identification of Cream Base Components via FTIR – V 2.0

Posted on By

Analytical Method Development: SOP for Identification of Cream Base Components via FTIR – V 2.0

Standard Operating Procedure for Identification of Cream Base Components via FTIR in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/263/2025
Supersedes SOP/AMD/263/2022
Page No. Page 1 of 11
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a validated procedure for the identification of cream base components such as emulsifying agents, emollients, and waxes using Fourier Transform Infrared

(FTIR) Spectroscopy with Attenuated Total Reflectance (ATR) technique.

2. Scope

This SOP applies to Analytical Method Development (AMD) and Quality Control (QC) teams responsible for identifying excipients present in cream formulations using FTIR spectroscopy during formulation development and raw material authentication.

3. Responsibilities

  • Analytical Scientist: Prepares samples, operates FTIR instrument, interprets spectra.
  • QC Analyst: Assists with sample handling and record maintenance.
  • QA Executive: Verifies spectral matches and approves documentation.
See also  Analytical Method Development: SOP for Discriminatory Dissolution Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the proper validation of the FTIR-based identification method and its application in routine and investigational analysis.

5. Procedure

5.1 Instrumentation

  1. FTIR Spectrophotometer equipped with ATR (e.g., ZnSe, diamond crystal)
  2. Resolution: 4 cm-1
  3. Scan range: 4000–650 cm-1

5.2 Sample Preparation

  1. Apply a thin layer (~0.05 g) of cream or isolate onto the ATR crystal.
  2. Ensure even contact between sample and crystal; avoid air gaps.
  3. Clean crystal before and after each measurement using alcohol and lint-free tissue.

5.3 Reference Standards

  1. Prepare FTIR spectra of individual cream base components such as:
    • Stearyl alcohol
    • Cetostearyl alcohol
    • White soft paraffin
    • Liquid paraffin
    • Polysorbate 60
    • Propylene glycol
  2. Store spectral library with spectral ID code and date (Annexure-2).

5.4 Measurement

  1. Run background scan without sample.
  2. Place sample and acquire 32 scans per spectrum.
  3. Compare sample spectrum with reference using software-based match algorithms (e.g., % correlation).
See also  Analytical Method Development: Growth Promotion Test Protocol Development - V 2.0

5.5 Interpretation and Reporting

  1. Match spectra with ≥ 90% correlation to reference library spectrum for identification confirmation.
  2. Check for presence of functional groups corresponding to:
    • O-H stretch (alcohols, ~3300 cm-1)
    • C-H stretch (alkanes, ~2850–2950 cm-1)
    • C=O stretch (esters, ~1730 cm-1)
  3. Document and attach spectra to Annexure-1.

5.6 Method Validation Parameters

  1. Specificity: Spectra must distinguish between structurally similar excipients (e.g., paraffin grades).
  2. Repeatability: Triplicate spectra must yield ≥ 95% similarity RSD ≤ 2%
  3. Ruggedness: Confirm reproducibility across analysts and instruments.

6. Abbreviations

  • FTIR: Fourier Transform Infrared
  • ATR: Attenuated Total Reflectance
  • QA: Quality Assurance
  • AMD: Analytical Method Development

7. Documents

  1. Sample Spectral Record – Annexure-1
  2. Spectral Library and Reference ID Table – Annexure-2
  3. Validation Summary Report – Annexure-3

8. References

  • USP <197K>: Infrared Spectroscopy
  • Ph. Eur. 2.2.24: Identification by Infrared Spectrophotometry
  • ICH Q2(R1): Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Priya Nair Manoj Joshi Sunita Reddy
Designation FTIR Analyst QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Sample Spectral Record

Sample ID Spectral Match (%) Component Identified Status
CRM-263-01 95.4% Cetostearyl Alcohol Pass

Annexure-2: Spectral Library and Reference ID Table

Component Spectrum ID Date Recorded Analyst
White Soft Paraffin WSP-01 10/04/2025 Priya Nair
Polysorbate 60 POL60-02 12/04/2025 Priya Nair

Annexure-3: Validation Summary Report

The FTIR method for identification of cream base excipients was validated using five components. Results showed ≥ 95% spectral similarity across triplicates with RSD ≤ 1.8%. The method is suitable for rapid qualitative identification of excipients in semi-solid formulations.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Added ATR specifics and spectral match acceptance criteria Annual Review Sunita Reddy
01/05/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Precision Study Using Repeatability Testing - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Absence of SOP for Deviation Trending: A Missed Opportunity in GMP Oversight
Next Post: Packaging: SOP for Visual Inspection of Packed Injectable Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version